HHS

Harte Hanks, Inc. (HHS) SWOT Analysis Analysis (2026)

Invetso Score: 3.8/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.8 (Moderate)

Scale and brand recognition in healthcare staffing support customer access and repeat demand, but peers with larger diversified platforms typically negotiate more favorable terms.

A current ratio of 1.30 indicates adequate near-term liquidity, which reduces funding stress versus weaker peers, though it is not a decisive operating advantage.

Cash conversion cycle of 43 days suggests working-capital discipline, helping preserve cash relative to peers with slower collections and inventory turnover.

Weaknesses

Score:

Return on invested capital of -6.3% shows capital is not earning its cost, leaving HHS structurally behind profitable peers on value creation.

Debt-to-equity of 1.57 indicates meaningful leverage, which constrains flexibility versus less levered peers and raises sensitivity to margin pressure.

Negative net debt to EBITDA reflects weak earnings capacity rather than balance-sheet strength, so peers with positive EBITDA have materially better resilience.

A 43-day cash conversion cycle ties up cash in operations, making HHS less efficient than peers with faster billing and collections.

Opportunities

Score:

If labor demand remains tight, staffing shortages can support pricing and utilization, benefiting HHS alongside peers with similar healthcare exposure.

Operational improvements in billing and collections could shorten the cash cycle, narrowing the working-capital gap versus more efficient competitors.

Portfolio focus on higher-margin service lines could lift returns, but peers with stronger scale and mix already hold an advantage.

Threats

Score:

Healthcare staffing remains highly competitive, so larger peers can use broader networks and scale to pressure pricing and win contracts.

Persistent negative returns increase the risk that peers with stronger profitability outinvest HHS in technology, recruiting, and client retention.

Leverage amplifies downside if reimbursement or demand weakens, leaving HHS more exposed than less indebted peers to earnings volatility.

Overall Score

Score:

HHS is structurally weaker than peers because negative returns and leverage outweigh its modest liquidity and working-capital discipline.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Harte Hanks, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →